Trestle Biotherapeutics
Bioengineered kidneys for patients with kidney failure
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
We are developing an implantable therapeutic tissue that will be surgically delivered to patients suffering from end stage renal disease. Upon implantation, this tissue will supplement the patient's renal function, eliminating their dependency on dialysis and improving their disease status. This has the potential to not only get these patients off dialysis - a significant impact for them and their families - but to greatly extend the time required before kidney transplantation is essential. Trestle Biotherapeutics is a Y Combinator company (Winter 2021). YC-listed status: Active.
- Website
- trestlebio.com
- Location
- San Diego, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Trestle Biotherapeutics — Developing implantable bioengineered kidney tissue to get end-stage renal disease patients off dialysis without a transplant. · Other
Links
- Y Combinator profileycombinator